These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6346608)

  • 21. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of procurement-related organ lesions on renal transplant outcome.
    Bentas W; Jones J; Urbschat A; Tilp U; Probst M; Scheuermann E; Hauser IA; Blaheta RA; Jonas D; Gossmann J
    Clin Transplant; 2008; 22(4):411-7. PubMed ID: 18261118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful kidney transplantation from a donation after cardiac death donor with acute renal failure and bowel infarction using extracorporeal support.
    Zuckerman JM; Singh RP; Farney AC; Rogers J; Hines MH; Stratta RJ
    Transpl Int; 2009 Aug; 22(8):798-804. PubMed ID: 19298251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of blood transfusions on the evoluation of the renal transplant].
    Andréu J; Caralps A; Brulles A; Ercilla G; Vives J; Masramón J; Lloveras J; Ricart MJ; Sola R
    Rev Clin Esp; 1980 Jan; 156(2):111-4. PubMed ID: 6988902
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Takahara S; Uchida K; Yoshimura N; Toma H; Oshima S; Sonoda T;
    Transplant Proc; 2005 May; 37(4):1800-3. PubMed ID: 15919471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose immunosuppressive therapy in kidney transplantation.
    Cheigh JS; Stenzel KH; Rubin AL
    Transplantation; 1982 Oct; 34(4):232-3. PubMed ID: 6755837
    [No Abstract]   [Full Text] [Related]  

  • 29. Late corticosteroid withdrawal can be safely performed for kidney recipients with stable graft function under pathological confirmation.
    Harada H; Miura M; Ogawa Y; Seki T; Taniguchi A; Takenouchi T; Togashi M; Hirano T
    Clin Transplant; 2006; 20 Suppl 15():26-32. PubMed ID: 16848872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Machine preservation of 450 cadaver kidneys.
    Merkel FK; Espe KB; Jensik SC
    Proc Eur Dial Transplant Assoc; 1980; 17():440-4. PubMed ID: 7017687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The renoprotective properties of xenon and argon in kidney transplantation.
    Zhao H; Rossaint R; Coburn M; Ma D;
    Eur J Anaesthesiol; 2017 Oct; 34(10):637-640. PubMed ID: 28872576
    [No Abstract]   [Full Text] [Related]  

  • 32. Failure to confirm the report that pitressin has a growth stimulating effect.
    REICHLIN S; BROWN JG
    Endocrinology; 1961 Aug; 69():394-6. PubMed ID: 13740465
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of pitressin on the peripheral circulation.
    de Langen CD
    Bibl Anat; 1965; 7():77-80. PubMed ID: 5860800
    [No Abstract]   [Full Text] [Related]  

  • 34. Morbid effects of pitressin on the rat kidney.
    Melissinos K; Papadimitriou DG; Bartsokas SK; Katapoti Z; Hadjiminas J
    J Endocrinol; 1973 Mar; 56(3):617-8. PubMed ID: 4733094
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacology of dopamine].
    Estanove S; du Grès B; Gressier M
    Ann Anesthesiol Fr; 1981; 22(1):75-83. PubMed ID: 6113807
    [No Abstract]   [Full Text] [Related]  

  • 36. The pitressin test of renal concentrating capacity; a comparative evaluation of the Addis-Shevky and Pitressin tests.
    BJERRE-CHRISTENSEN K
    Acta Med Scand; 1952 Mar; 142(3):215-30. PubMed ID: 12976007
    [No Abstract]   [Full Text] [Related]  

  • 37. Daily variability of the fluid restriction and pitressin concentration tests for renal function.
    LITTLE JM; ANDERSON GA
    Am J Med; 1948 Mar; 4(3):466. PubMed ID: 18933726
    [No Abstract]   [Full Text] [Related]  

  • 38. Intensive care management of paediatric organ donors and its effect on post-transplant organ function.
    Finfer S; Bohn D; Colpitts D; Cox P; Fleming F; Barker G
    Intensive Care Med; 1996 Dec; 22(12):1424-32. PubMed ID: 8986499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organ procurement in patients with fatal head injuries. The fate of the potential donor.
    Mackersie RC; Bronsther OL; Shackford SR
    Ann Surg; 1991 Feb; 213(2):143-50. PubMed ID: 1992941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dopamine and pitressin on kidneys procured and harvested for transplantation.
    Schneider A; Toledo-Pereyra LH; Zeichner WD; Allaben R; Whitten J
    Transplantation; 1983 Jul; 36(1):110-1. PubMed ID: 6346608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.